Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/6838
Title: Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study
Authors: Atallah, Natalie J
Panossian, Vahe S
Atallah, Christine J
Schwabe, Andrej
Johannes, Sascha
Wiemer, Jan
Mansour, Michael K
Affiliations: Faculty of Medicine 
Keywords: COVID-19
ICU
MR-proADM
Biomarkers; viral pneumonia
Issue Date: 2022-08-24
Part of: Open Forum Infectious Diseases
Volume: 9
Issue: 9
Abstract: 
Mid-regional proadrenomedullin (MR-proADM) is a biomarker released following endothelial damage. Studies have shown a correlation in predicting coronavirus disease 2019 (COVID-19) outcomes with MR-proADM levels. Our study aimed to investigate baseline MR-proADM as a predictor of a wider range of clinical outcomes of varying severity in patients admitted with COVID-19, and to compare to other biomarkers.
URI: https://scholarhub.balamand.edu.lb/handle/uob/6838
ISSN: 2328-8957
DOI: 10.1093/ofid/ofac423
Ezproxy URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

Google ScholarTM

Check

Dimensions Altmetric

Dimensions Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.